Matthew Winton - COO at Inozyme Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Coo
Stock Symbol
INZY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Winton since 10/7/2024

Holdings reported by Matthew Winton for Inozyme Pharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 0 $185K $4.45 Jul 1, 2025 Direct Common Stock
Common Stock 0 $0 $4.00 Jul 1, 2025 Direct
Stock Option (Right to Buy) 0 Jul 1, 2025 Direct Common Stock

Transactions reported by Matthew Winton for Inozyme Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.